Tokyo Guidelines Cholangitis Severity (TG18)
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Grade I (mild)1–1
- Grade II (moderate)2–2
- Grade III (severe)3–3
The Tokyo Guidelines Cholangitis Severity (TG18) calculates assessing gastrointestinal disease severity, endoscopic intervention urgency, and rebleeding risk. Key inputs include organ cardiovascular. Scores guide timing emergent endoscopy, initiating high-dose proton pump inhibitor infusions, or obtaining surgical consultation. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Tokyo Guidelines 2018 (TG18) severity grading for acute cholangitis. Grade III (severe): any organ dysfunction. Grade II (moderate): no organ dysfunction but ≥2 of: WBC >12,000/<4,000, fever ≥39°C, age ≥75, bilirubin ≥5 mg/dL, albumin <0.7×LLN. Grade I (mild): neither.
Clinical Indication
The Tokyo Guidelines Cholangitis Severity (TG18) is indicated for bedside clinical practice to support Tokyo Guidelines 2018 (TG18) severity grading for acute cholangitis. Grade III (severe): any organ dysfunction. Grade II (moderate): no organ dysfunction but ≥2 of: WBC >12,000/<4,000, fever ≥39°C, age ≥75, bilirubin ≥5 mg/dL, albumin <0.7×LLN. Grade I (mild): neither.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.
Limitations & Contraindications
Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration.
Clinical Pearls & Action Plan
Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy.
Grade III if any organ dysfunction; else Grade II if ≥2 predictors; else Grade I
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| organ_cardiovascular | string | Yes | Cardiovascular dysfunction (hypotension requiring vasopressors) |
| organ_neurological | string | Yes | Neurological dysfunction (disturbance of consciousness) |
| organ_respiratory | string | Yes | Respiratory dysfunction (PaO2/FiO2 ratio <300) |
| organ_renal | string | Yes | Renal dysfunction (oliguria or creatinine >2.0 mg/dL) |
| organ_hepatic | string | Yes | Hepatic dysfunction (PT-INR >1.5) |
| organ_hematologic | string | Yes | Hematologic dysfunction (platelets <100,000/mm³) |
| wbc_abnormal | string | Yes | WBC >12,000 or <4,000 per mm³ |
| fever_ge_39 | string | Yes | Fever ≥39°C |
| age_ge_75 | string | Yes | Age ≥75 years |
| bilirubin_ge_5 | string | Yes | Total bilirubin ≥5 mg/dL |
| albumin_low | string | Yes | Albumin <0.7× lower limit of normal |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 1–1 | Grade I (mild) | Grade I (mild) acute cholangitis |
| 2–2 | Grade II (moderate) | Grade II (moderate) acute cholangitis |
| 3–3 | Grade III (severe) | Grade III (severe) acute cholangitis |
Evidence-Based References (EBM)
- Kiriyama S, Kozaka K, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis. J Hepatobiliary Pancreat Sci. 2018;25(1):17-30.